ApexOnco's Jacob Plieth shares his take on what to watch for at the 2024 ASH Annual Meeting
London Healthcare Week: Forbion Managing Partner Sander Slootweg shares his thoughts on the year ahead, the IPO market, M&A environment, areas of interest, and more
From Seoul: Kicking off BiotechTV's one week visit to Korea by getting an overview of the growth and current state of biotech in the country from KoreaBIO
SITC 2024: Parker Institute for Cancer Immunotherapy CSO John Connolly gives an overview of the latest advances in IO
BioHouston CEO Ann Tanabe kicks off the 2024 Texas Life Science Forum
BIO-Europe: Pareto Securities' Biotech Analyst Dan Akschuti shares his thoughts on the conference and discusses recent company successes in the nordic region
BIO-Europe: Karolinska Institutet professor and physician Anna Wedell discusses the work she is doing and what areas of research excite her today
BIO-Europe: The CEO of Flerie, a publicly traded life sciences investment firm, discuses the firm's investment strategy and the health of biotech in the region
The CEO of the nonprofit MassChallenge describes the way it supports startups and entrepreneurs, and why it has chosen Dallas as its second region of major focus in the U.S. outside of Boston
Biotech entrepreneur RA Session II describes converting science from UT Southwestern into companies - he currently has a new one that is in stealth mode
The CEO of LH Capital, a key supporter of the life sciences industry in North Texas, describes the progress the biotech community here has made over the last year
UT Southwestern professor Philipp Scherer talks about his work focusing on adipose cells and a local biotech company, PriveBio, that has come out of it
Piper Sandler analyst Biren Amin discusses recent news in ATTR cardiomyopathy, ophthalmology, Duchenne muscular dystrophy, and more
Backed by a conglomerate that has pharma expertise, Rome based Angelini Ventures has a $300M fund that invests broadly in life sciences and healthcare
The Foundation for Innovation and Tech Transfer has consolidated business development and tech transfer for 7 institutions in northern Italy to expedite the commercialization of the area's research
The co-founder of the startup Ousia Pharma describes working from Copenhagen's BioInnovation Institute on his company's next-generation enhancer to GLPs
Biotech veteran Hans Schikan gives an overview of the Netherlands' life sciences scene
Mizuho senior analyst Graig Suvannavejh joins BiotechTV for Analyst Thursdays from Kendall Square
Vedanta Biosciences founder and CEO Bernat Olle shares an expert take on microbiome drug development
Biotech lab technologies expert Bob Gantzer talks about the digital lab book, rovers, and future technologies still to come in biotech
.png){kind=logo}
